Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary Endotheliopathy
Latest Information Update: 30 Nov 2021
At a glance
- Drugs Iloprost (Primary)
- Indications Adult respiratory distress syndrome; COVID 2019 infections; Respiratory insufficiency
- Focus Therapeutic Use
- Acronyms COMBAT-COVID; COMBAT-COVID-19
- 23 Nov 2021 Primary endpoint has not been met (Mechanical ventilation free days) , according to Results published in the American Journal of Respiratory and Critical Care Medicine
- 23 Nov 2021 Results published in the American Journal of Respiratory and Critical Care Medicine
- 21 May 2021 Status changed from active, no longer recruiting to completed.